Search

Pulmatrix Inc

Closed

1.6 -3.03

Overview

Share price change

24h

Current

Min

1.6

Max

1.65

Key metrics

By Trading Economics

Income

-244K

-1.2M

EPS

-0.321

Employees

2

EBITDA

-244K

-1.2M

Market Stats

By TradingEconomics

Market Cap

1.7M

6.3M

Previous open

4.63

Previous close

1.6

Pulmatrix Inc Chart

Past performance is not a reliable indicator of future results.

Related News

19 Jul 2026, 23:51 UTC

Bitcoin dips amid crypto volatility, while Ethereum rises; South Korea's GDP trends and geopolitical tensions raise concerns for regional market stability.

19 Jul 2026, 23:51 UTC

"Bitcoin dips as Ethereum rises amid geopolitical tensions and South Korea's GDP data, with key economic indicators on the horizon."

19 Jul 2026, 23:51 UTC

"Bitcoin Declines Amid Mixed Crypto Performance; South Korea's GDP and ASEAN Interest Rate Talks Signal Potential Market Shifts."

19 Jul 2026, 23:51 UTC

Mixed cryptocurrency performance amid geopolitical tensions and economic uncertainties, with South Korea's GDP figures and rising U.S. margin debt raising investor concerns.

19 Jul 2026, 23:51 UTC

Bitcoin is trading lower today, continuing a trend following Friday's declines in U.S. equity markets. It remains above its 20-day moving average.

19 Jul 2026, 23:41 UTC

Canada's New Housing Price Index set for July 24, with a forecasted decline of -0.2% amid cautious market sentiment and ongoing economic pressures.

19 Jul 2026, 23:21 UTC

Upcoming Chicago Fed National Activity Index release on July 23, 2026, may signal U.S. economic growth amidst mixed sentiment and inflation concerns.

19 Jul 2026, 23:21 UTC

Canada's Retail Sales Ex Autos Expected to Rise 0.4% in May Amid Cautious Optimism on Consumer Spending

19 Jul 2026, 23:11 UTC

Correlated Moves

During after-market hours, SGD/CHF is higher, reflecting a slight gain since Friday's close. The asset exhibited notable volatility amid broader macroeconomic trends.

19 Jul 2026, 23:11 UTC

ECB Expected to Maintain Interest Rate at 2.4% Amid Rising Energy Costs and Global Economic Concerns

19 Jul 2026, 23:11 UTC

Euro Area's Deposit Facility Rate Expected to Hold Steady at 0.0225% Amid Cautious Market Sentiment and Geopolitical Tensions

19 Jul 2026, 23:01 UTC

China's Loan Prime Rate Expected to Hold Steady at 3.50% Amid Cautious Economic Sentiment and Geopolitical Tensions Ahead of July Release

19 Jul 2026, 23:01 UTC

China's Loan Prime Rate (LPR) 1Y release on July 20, 2026, forecasted at a cautious 0.03%, amid economic concerns impacting consumer spending and credit demand.

19 Jul 2026, 23:01 UTC

After-market trading for GBP/ZAR shows gains since Friday's close, fluctuating throughout the session and remaining near the upper end of its one-month range.

19 Jul 2026, 23:01 UTC

Macro News
Correlated Moves

GBP/USD declines in after-hours trading as the U.S. dollar strengthens against major currencies, reflecting broader investor sentiment and geopolitical tensions.

19 Jul 2026, 23:01 UTC

GBP/CHF is higher in after-market trading, reaching the upper end of its one-month trading range despite no specific news identified for today's move.

19 Jul 2026, 22:51 UTC

USD/NOK is trading higher in after-market hours, moving from a low to a high since Friday's close, despite remaining below its 20-day moving average.

19 Jul 2026, 22:31 UTC

Japan's Inflation Rate Release on July 23, 2026: Market Eyes Potential Impact of Recent Economic Shifts and Extreme Weather on Monetary Policy.

19 Jul 2026, 22:31 UTC

Japan's Core Inflation Rate Expected to Rise to 1.6% Amid Economic Concerns and Geopolitical Tensions Ahead of July Release

19 Jul 2026, 22:21 UTC

GBP/NOK is higher in after-hours trading, reaching the upper end of its one-month range. No specific news was identified for this price move.

19 Jul 2026, 22:21 UTC

EUR/SEK advanced in after-market trading, reaching a peak above previous levels. The performance contrasts with its position in the one-month trading range.

19 Jul 2026, 22:21 UTC

Mortgage Rates Hit Nine-Month High at 6.65%, Raising Concerns Over Housing Affordability and Consumer Spending Ahead of Upcoming MBA Data Release

19 Jul 2026, 22:21 UTC

Canada's June 2026 Inflation Rate Release Sparks Caution Amid Rising Gas Prices and Mixed Market Expectations

19 Jul 2026, 22:21 UTC

Canada's Inflation Rate Expected to Decrease by 0.002% in June, Signaling Potential Deflationary Pressures Ahead of July Release

19 Jul 2026, 22:21 UTC

Canada's Core Inflation Rate Release on July 20, 2026 Expected to Impact Monetary Policy Amid Ongoing Economic Pressures.

19 Jul 2026, 22:21 UTC

Correlated Moves

Avalanche is declining during Sunday’s session, reflecting broader cryptocurrency market sentiment. The asset remains below its 20-day moving average.

19 Jul 2026, 22:11 UTC

Correlated Moves

Gold/CAD is declining in the ongoing session, continuing a downward trend since Friday's close, with Silver also showing weakness.

19 Jul 2026, 22:11 UTC

Correlated Moves

Gold Ounce vs Euro is trading lower, reflecting a decline since Friday's close, influenced by a drop in Silver prices and macroeconomic factors.

19 Jul 2026, 22:11 UTC

Correlated Moves

Gold/JPY is trading lower, continuing a decline since Friday's close. The asset remains below its 20-day moving average amid broader weakness in precious metals.

19 Jul 2026, 22:11 UTC

Macro News

Crude oil prices are rising amid concerns over shipping route disruptions and escalating U.S.-Iran tensions. Prices have regained momentum above the 20-day moving average.

Peer Comparison

Price change

Pulmatrix Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.
help-icon Live chat